Compare ALLT & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALLT | SLP |
|---|---|---|
| Founded | 1996 | 1996 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | EDP Services |
| Sector | Telecommunications | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 381.1M | 371.9M |
| IPO Year | 2006 | 1996 |
| Metric | ALLT | SLP |
|---|---|---|
| Price | $7.97 | $18.41 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 6 |
| Target Price | $12.40 | ★ $24.00 |
| AVG Volume (30 Days) | ★ 242.4K | 148.8K |
| Earning Date | 05-12-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | ★ $59,577,000.00 |
| Revenue This Year | $15.84 | $3.80 |
| Revenue Next Year | $12.09 | $5.90 |
| P/E Ratio | $469.21 | ★ $42.83 |
| Revenue Growth | N/A | ★ 10.52 |
| 52 Week Low | $6.12 | $11.09 |
| 52 Week High | $11.92 | $21.01 |
| Indicator | ALLT | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 56.50 | 58.63 |
| Support Level | $7.38 | $18.22 |
| Resistance Level | $8.12 | $18.46 |
| Average True Range (ATR) | 0.25 | 0.02 |
| MACD | 0.06 | -0.01 |
| Stochastic Oscillator | 59.82 | 37.50 |
Allot Ltd is a provider of security and network intelligence solutions for mobile, fixed, and cloud service providers, as well as enterprises. It offers network-based security solutions such as mobile security, DDoS protection, and IoT security, along with network analytics and traffic management. It focuses on expanding its Security-as-a-Service (SECaaS) offerings through the Allot Secure product family, which delivers unified protection for consumers and SMBs across mobile, fixed, and 5G networks. Its Allot Smart solutions enable service providers to analyze and manage network data, optimize performance, reduce costs, and enhance user experience. It has a customer base in Europe, which generates maximum revenue, as well as in Asia and Oceania, the Americas, the Middle East, and Africa.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.